Table 1 Demographic patient data and dosage and consumption of anesthetic drugs
Study group n = 32 | Control group n = 30 | p | |
|---|---|---|---|
BMI (kg m-2) | 27.3 ± 4.8 | 28.9 ± 5.0 | 0.18 |
Male/Female (n) | 19/13 | 24/6 | 0.18 |
ASA I/II/III (n) | 0/0/32 | 0/0/30 | 1.0 |
Chronic beta-blocker therapy (n) | 32/32 | 30/30 | |
Remifentanil (maximum infusion rate in μg kg-1 min-1) | |||
before sternotomy | 2.0 [0.0 - 6.0] | - | n.a. |
during sternotomy | 3.0 [2.0 - 7.0] | - | n.a. |
after sternotomy | 2.5 [0.3 - 7.0] | - | n.a. |
Cumulative opioid doses before sternotomy | |||
Sufentanil (μg) | 345 ± 68 | 355 ± 45 | 0.5 |
Remifentanil (mg) | 6.2 [1.1 - 22.1] | - | n.a. |